Results 281 to 290 of about 238,767 (310)
Some of the next articles are maybe not open access.
Journal of Allergy and Clinical Immunology, 2005
The Toll-like receptors (TLRs) are a recently discovered family of receptors involved in the innate recognition of pathogens. TLRs have much homology to the IL-1 receptor family and the Drosophila Toll protein, and at least 10 distinct TLRs have now been identified in human subjects (Fig 1).
Pierre Fiset +2 more
openaire +3 more sources
The Toll-like receptors (TLRs) are a recently discovered family of receptors involved in the innate recognition of pathogens. TLRs have much homology to the IL-1 receptor family and the Drosophila Toll protein, and at least 10 distinct TLRs have now been identified in human subjects (Fig 1).
Pierre Fiset +2 more
openaire +3 more sources
Toll‐like Receptors in Autoimmunity
Annals of the New York Academy of Sciences, 2008Both genetic predispositions and environmental factors contribute to the development of autoimmunity. Toll‐like receptors (TLR) are a family of pattern recognition receptors (PRRs), and their stimulus by pathogen‐associated molecular patterns (PAMPs) and damage‐associated molecular patterns (DAMPs) is an important prerequisite for the induction of ...
Maria Fischer, Marc Ehlers
openaire +3 more sources
Toll-like receptors in the skin
Seminars in Immunopathology, 2007Toll-like receptors (TLRs) are important pattern-recognition receptors involved in host defense against a variety of pathogenic microorganisms. Activation of TLRs leads to the production of cytokines, chemokines, antimicrobial peptides, and upregulation costimulatory and adhesion molecules involved in innate and adaptive immune responses.
Lloyd S. Miller, Robert L. Modlin
openaire +3 more sources
Trends in Molecular Medicine, 2002
A mammalian immune response to microbial organisms requires a series of pattern recognition steps, and nonspecific processes often precede elements of the specific immune system in this process. Molecules such as lipopolysaccharide, peptidoglycan and lipoteichoic acids are relatively conserved, and are recognized in this manner by toll-like receptors ...
openaire +3 more sources
A mammalian immune response to microbial organisms requires a series of pattern recognition steps, and nonspecific processes often precede elements of the specific immune system in this process. Molecules such as lipopolysaccharide, peptidoglycan and lipoteichoic acids are relatively conserved, and are recognized in this manner by toll-like receptors ...
openaire +3 more sources
2001
Molecular recognition of bacterial, non-self molecules is a critical event in the initiation of innate immune responses. This important function has been conserved throughout evolution from insects to humans (1–4). Several host cell surface receptors mediating this function have been identified.
openaire +2 more sources
Molecular recognition of bacterial, non-self molecules is a critical event in the initiation of innate immune responses. This important function has been conserved throughout evolution from insects to humans (1–4). Several host cell surface receptors mediating this function have been identified.
openaire +2 more sources
Annals of Allergy, Asthma & Immunology, 2002
To review the role of mammalian Toll-like receptors (TLRs) in host defense.MEDLINE search and current literature.First, TLRs participate in the recognition of molecular patterns present on microorganisms. Second, TLRs are expressed at the interface with the environment, the site of microbial invasion.
openaire +3 more sources
To review the role of mammalian Toll-like receptors (TLRs) in host defense.MEDLINE search and current literature.First, TLRs participate in the recognition of molecular patterns present on microorganisms. Second, TLRs are expressed at the interface with the environment, the site of microbial invasion.
openaire +3 more sources
, 2015 Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly